HONK and lithium-induced nephrogenic diabetes 41 atten-tion paid to plasma sodium concentrations and urine output.
units/ml). There was no family history of hereditary angioedema. Furthermore, at her initial presentation, she stated that she had never had a menstrual period and on examination had features ofTurner's syndrome with short stature, wide carrying angle and a webbed neck (cardiovascular examination was normal). Subsequent chromosomal analysis showed a mosaic karyotype consisting of one cell line with monosomy X and a second cell line with a 46 XY component. Serum oestradiol was undetectable and gonadotropin levels were raised (follicle-stimulating hormone 53.8 IU/I (<21), luteinising hormone 21.8 IU/l (<57)).
The patient was given tranexamic acid as prophylaxis for attacks which occurred with a maximum frequency of one every six weeks, but she obtained little benefit. Gonadectomy was advised because of the risk of developing gonadoblastoma' and hormone replacement therapy was withheld until the operation had been performed. Two streak ovaries were removed laparoscopically and there was no histological evidence of malignancy.
Postoperatively, hormone replacement therapy was commenced with combined conjugated oestrogen (625 jig) and progesterone but within six weeks, the patient experienced a three-to four-fold increase in the frequency of her attacks of angioedema to one attack every 10-14 days. The attacks were more severe and lasted on average two hours longer. Treatment with danazol (following discontinuation of tranexamic acid) was introduced at a dose of 200 mg daily and complete remission was induced (currently for six months). There have been no abnormalities in liver function tests.
Discussion
Hereditary angioedema is an autosomal dominant disease due to mutations within the C1 inhibitor gene. This leads to plasma deficiency of C 1 inhibitor and allows the auto-activation of Cl and consumption of C2 and C4. The coexistence of Turner's syndrome and hereditary angioedema has not previously been described and we hypothesise that the angioedema would have declared itself at a younger age in our patient if she had had normal oestradiol production from normal ovaries. In a recent review of 226 patients with hereditary angioedema, only 1% presented at age greater than 30 years. 2 There are three arms to treatment: longterm and short-term prophylaxis, and treat- In conclusion, the highly unusual coincidence of Turner's syndrome in a patient with hereditary angioedema highlights the deleterious effects of oestrogens in the latter condition, even when given in physiological replacement doses. Treatment with attenuated androgens such as danazol reverses this effect.
